Mercator Medical SA (0QJM) Stock Statistics & Valuation Metrics
Total Valuation
Mercator Medical SA has a market cap or net worth of PLN 502.17M. The enterprise value is PLN 296.36M.
- Market Cap
- PLN 502.17M
- Enterprise Value
- PLN 296.36M
Share Statistics
Mercator Medical SA has 9,144,813 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 9,144,813
- Owned by Insiders
- ―
- Owned by Institutions
- <0.01%
Financial Efficiency
Mercator Medical SA’s return on equity (ROE) is 0.03 and return on invested capital (ROIC) is -1.52%.
- Return on Equity (ROE)
- 0.03
- Return on Assets (ROA)
- 0.03
- Return on Invested Capital (ROIC)
- -1.52%
- Return on Capital Employed (ROCE)
- -0.02
- Revenue Per Employee
- 689.29K
- Profits Per Employee
- 34.32K
- Employee Count
- 833
- Asset Turnover
- 0.56
- Inventory Turnover
- 2.40
Valuation Ratios
The current PE Ratio of Mercator Medical SA is 7.99. Mercator Medical SA’s PEG ratio is 0.03.
- PE Ratio
- 7.99
- PS Ratio
- 0.86
- PB Ratio
- 0.56
- Price to FCF
- 22.48
- Price to Operating Cash Flow
- 7.88
- PEG Ratio
- 0.03
Income Statement
In the last 12 months, Mercator Medical SA had revenue of 574.18M and earned 28.59M in profits. Earnings per share was 3.10.
- Revenue
- 574.18M
- Gross Profit
- 109.60M
- Operating Income
- -14.21M
- Pretax Income
- 28.40M
- Net Income
- 28.59M
- EBITDA
- 14.56M
- Earnings Per Share (EPS)
- 3.10
Cash Flow
In the last 12 months, operating cash flow was 67.45M and capital expenditures -43.82M, giving a free cash flow of 23.64M billion.
- Operating Cash Flow
- 67.45M
- Free Cash Flow
- 23.64M
- Free Cash Flow per Share
- 2.58
Dividends & Yields
Mercator Medical SA pays an annual dividend of ―, resulting in a dividend yield of 3.16%
- Dividend Per Share
- ―
- Dividend Yield
- 3.16%
- Payout Ratio
- N/A
- Free Cash Flow Yield
- 4.45%
- Earnings Yield
- 12.52%
Stock Price Statistics
- Beta
- ―
- 52-Week Price Change
- 0.00%
- 50-Day Moving Average
- 357.85
- 200-Day Moving Average
- 357.85
- Relative Strength Index (RSI)
- ―
- Average Volume (3m)
- 171
Important Dates
Mercator Medical SA upcoming earnings date is Nov 30, 2026, TBA (Not Confirmed).
- Last Earnings Date
- Sep 30, 2026
- Next Earnings Date
- Nov 30, 2026
- Ex-Dividend Date
- ―
Financial Position
Mercator Medical SA as a current ratio of 5.09, with Debt / Equity ratio of 2.54%
- Current Ratio
- 5.09
- Quick Ratio
- 3.12
- Debt to Market Cap
- 0.01
- Net Debt to EBITDA
- -8.10
- Interest Coverage Ratio
- -23.77
Taxes
In the past 12 months, Mercator Medical SA has paid -946.00K in taxes.
- Income Tax
- -946.00K
- Effective Tax Rate
- -0.03
Enterprise Valuation
Mercator Medical SA EV to EBITDA ratio is 4.97, with an EV/FCF ratio of 17.68.
- EV to Sales
- 0.67
- EV to EBITDA
- 4.97
- EV to Free Cash Flow
- 17.68
- EV to Operating Cash Flow
- 6.19
Balance Sheet
Mercator Medical SA has PLN 170.68M in cash and marketable securities with PLN 24.96M in debt, giving a net cash position of PLN 145.72M billion.
- Cash & Marketable Securities
- PLN 170.68M
- Total Debt
- PLN 24.96M
- Net Cash
- PLN 145.72M
- Net Cash Per Share
- PLN 15.93
- Tangible Book Value Per Share
- PLN 100.50
Margins
Gross margin is 27.29%, with operating margin of 7.80%, and net profit margin of 10.72%.
- Gross Margin
- 27.29%
- Operating Margin
- 7.80%
- Pretax Margin
- 11.51%
- Net Profit Margin
- 10.72%
- EBITDA Margin
- 13.55%
- EBIT Margin
- 8.60%
Analyst Forecast
The average price target for Mercator Medical SA is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- 0
- Revenue Growth Forecast
- 7.04%
- EPS Growth Forecast
- 8.80%